T. Rowe Price Associates
NUTX

T. Rowe Price Associates’s Nutex Health NUTX Stock Holding History

T. Rowe Price Associates’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705K Buy
4,120
+472
+13% +$59.8K ﹤0.01% 2469
2026
Q1 		$347K Buy
3,648
+1,588
+77% +$195K ﹤0.01% 2616
2025
Q4 		$340K Buy
+2,060
New +$273K ﹤0.01% 2581
2025
Q3 		– Sell
-1,717
Closed -$214K – 3093
2025
Q2 		$214K Buy
+1,717
New +$222K ﹤0.01% 2683
2023
Q2 		– Sell
-299
Closed -$46K – 2922
2023
Q1 		$46K Buy
299
+4
+1% +$810 ﹤0.01% 2799
2022
Q4 		$84K Buy
+295
New +$56.7K ﹤0.01% 2748

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

T. Rowe Price Associates's NUTX Position: Q2 2026 in Review

T. Rowe Price Associates increased its Nutex Health (NUTX) stake by 13% in Q2 2026, buying an estimated $59.8K and bringing the position to 4,120 shares worth $705K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

T. Rowe Price Associates first reported a position in NUTX in Q4 2022 and has held it in 6 quarters since. 153 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • T. Rowe Price Associates held 4,120 shares of Nutex Health worth $705K as of Q2 2026.
  • T. Rowe Price Associates bought 472 Nutex Health shares in Q2 2026, an estimated $59.8K.
  • Nutex Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2469 holding.
  • T. Rowe Price Associates first reported a position in Nutex Health in Q4 2022 and has held it in 6 quarters since.
  • 153 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.